Maravai LifeSciences Holdings, Inc. Operating Cash Flow
Maravai LifeSciences Holdings, Inc. (MRVI) reported Operating Cash Flow of $12.66 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-07
- Maravai LifeSciences Holdings, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was $3.99M.
- Maravai LifeSciences Holdings, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was $8.66M.
- Maravai LifeSciences Holdings, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$22.77M.
- Maravai LifeSciences Holdings, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$15.15M, a 215.33% decline year-over-year.
- Maravai LifeSciences Holdings, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$57.57M, a 871.24% decline from fiscal 2024.
- Maravai LifeSciences Holdings, Inc. net cash provided by (used in) operating activities for fiscal 2024 was $7.46M, a 94.09% decline from fiscal 2023.
- Maravai LifeSciences Holdings, Inc. net cash provided by (used in) operating activities for fiscal 2023 was $126.22M, a 76.45% decline from fiscal 2022.
- Maravai LifeSciences Holdings, Inc. net cash provided by (used in) operating activities for fiscal 2022 was $535.98M, a 45.42% increase from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $12.66M 10-Q · filed 2026-08-07 | -$10.11M derived: sum of 3 quarters · filed 2026-08-07 | -$25.26M derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2026-03-31 | $8.66M 10-Q · filed 2026-05-08 | -$14.10M derived: sum of 2 quarters · filed 2026-05-08 | -$29.25M derived: sum of 3 quarters · filed 2026-05-08 | -$39.52M derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2025-12-31 | -$22.77M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$37.92M derived: sum of 2 quarters · filed 2026-02-26 | -$48.18M derived: sum of 3 quarters · filed 2026-08-07 | -$57.57M 10-K · filed 2026-02-26 | |||
| 2025-09-30 | -$15.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$25.41M derived: sum of 2 quarters · filed 2026-08-07 | -$34.80M 10-Q · filed 2025-11-07 | -$49.44M derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2025-06-30 | -$10.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$19.66M 10-Q · filed 2026-08-07 | -$34.29M derived: sum of 3 quarters · filed 2026-08-07 | -$21.16M derived: sum of 4 quarters · filed 2026-08-07 | |||
| 2025-03-31 | -$9.39M 10-Q · filed 2026-05-08 | -$24.03M derived: sum of 2 quarters · filed 2026-05-08 | -$10.89M derived: sum of 3 quarters · filed 2026-05-08 | $6.54M derived: sum of 4 quarters · filed 2026-05-08 | |||
| 2024-12-31 | -$14.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$1.50M derived: sum of 2 quarters · filed 2026-02-26 | $15.93M derived: sum of 3 quarters · filed 2026-02-26 | $7.46M 10-K · filed 2026-02-26 | |||
| 2024-09-30 | $13.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $30.57M derived: sum of 2 quarters · filed 2025-11-07 | $22.10M 10-Q · filed 2025-11-07 | $29.89M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-06-30 | $17.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $8.97M 10-Q · filed 2025-08-11 | $16.76M derived: sum of 3 quarters · filed 2026-02-26 | $30.92M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2024-03-31 | -$8.47M 10-Q · filed 2025-05-12 | -$677.00K derived: sum of 2 quarters · filed 2026-02-26 | $13.49M derived: sum of 3 quarters · filed 2026-02-26 | $32.68M derived: sum of 4 quarters · filed 2026-02-26 | |||
| 2023-12-31 | $7.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $21.96M derived: sum of 2 quarters · filed 2026-02-26 | $41.15M derived: sum of 3 quarters · filed 2026-02-26 | $126.22M 10-K · filed 2026-02-26 | |||
| 2023-09-30 | $14.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $33.36M derived: sum of 2 quarters · filed 2024-11-12 | $118.43M 10-Q · filed 2024-11-12 | $217.77M derived: sum of 4 quarters · filed 2025-03-18 | |||
| 2023-06-30 | $19.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $104.27M 10-Q · filed 2024-08-08 | $203.60M derived: sum of 3 quarters · filed 2025-03-18 | $313.66M derived: sum of 4 quarters · filed 2025-03-18 | |||
| 2023-03-31 | $85.07M 10-Q · filed 2024-05-09 | $184.41M derived: sum of 2 quarters · filed 2025-03-18 | $294.47M derived: sum of 3 quarters · filed 2025-03-18 | $458.75M derived: sum of 4 quarters · filed 2025-03-18 | |||
| 2022-12-31 | $99.33M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $209.39M derived: sum of 2 quarters · filed 2025-03-18 | $373.67M derived: sum of 3 quarters · filed 2025-03-18 | $535.98M 10-K · filed 2025-03-18 | |||
| 2022-09-30 | $110.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $274.34M derived: sum of 2 quarters · filed 2023-11-08 | $436.64M 10-Q · filed 2023-11-08 | $495.38M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2022-06-30 | $164.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $326.58M 10-Q · filed 2023-08-08 | $385.33M derived: sum of 3 quarters · filed 2024-02-29 | $490.89M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2022-03-31 | $162.30M 10-Q · filed 2023-05-09 | $221.05M derived: sum of 2 quarters · filed 2024-02-29 | $326.61M derived: sum of 3 quarters · filed 2024-02-29 | $492.55M derived: sum of 4 quarters · filed 2024-02-29 | |||
| 2021-12-31 | $58.74M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $164.31M derived: sum of 2 quarters · filed 2024-02-29 | $330.24M derived: sum of 3 quarters · filed 2024-02-29 | $368.57M 10-K · filed 2024-02-29 | |||
| 2021-09-30 | $105.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $271.50M derived: sum of 2 quarters · filed 2022-11-04 | $309.83M 10-Q · filed 2022-11-04 | $310.40M 10-Q · filed 2021-11-15 | $389.26M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2021-06-30 | $165.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $204.26M 10-Q · filed 2022-08-05 | $204.55M 10-Q · filed 2021-08-11 | $283.70M derived: sum of 3 quarters · filed 2023-02-28 | $335.12M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2021-03-31 | $38.33M 10-Q · filed 2022-05-06 | $38.72M 10-Q · filed 2021-05-12 | $117.76M derived: sum of 2 quarters · filed 2023-02-28 | $169.19M derived: sum of 3 quarters · filed 2023-02-28 | $180.80M derived: sum of 4 quarters · filed 2023-02-28 | ||
| 2020-12-31 | $79.43M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $130.86M derived: sum of 2 quarters · filed 2023-02-28 | $142.47M derived: sum of 3 quarters · filed 2023-02-28 | $152.19M 10-K · filed 2023-02-28 | |||
| 2020-09-30 | $51.43M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $63.04M derived: sum of 2 quarters · filed 2021-11-15 | $72.76M 10-Q · filed 2021-11-15 | ||||
| 2020-06-30 | $11.62M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $21.33M 10-Q · filed 2021-08-11 | |||||
| 2020-03-31 | $9.71M 10-Q · filed 2021-05-12 | ||||||
| 2019-12-31 | $24.11M 10-K · filed 2022-03-01 |